Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Evaluation of Different Hemostatic Agents on Clinical and Radiographic Success of TheraCal PT Pulpotomy in Primary Molars With Reversible Pulpitis: A Randomized Controlled Trial

NCT07876934 is registered in ClinicalTrials.gov with Reem Mohamed Gaber as lead sponsor.

NCT NCT07876934
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07876934 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Evaluation of Different Hemostatic Agents on Clinical and Radiographic Success of TheraCal PT Pulpotomy in Primary Molars With Reversible Pulpitis: A Randomized Controlled Trial
Lead sponsor
Reem Mohamed Gaber
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 1, 2027
Completion date
December 1, 2027
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dental caries, dental pulp exposure, primary molar pulpotomy, reversible pulpitis